Family Medicine · Harrisburg, AR
NPI
1467448837
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
802 Illinois
Harrisburg, AR, 72432
Phone (870) 578-5443
Groups this clinician bills Medicare through
Medicare paid, 2024
$135K
9,024 services
Medicare patients, 2024
382
Average age 75
Drug cost, 2024
$2.6M
26,380 prescriptions
Company payments, 2025
$7,163
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vonda G Houchin was code J1010 (injection, methylprednisolone acetate, 1 mg), 4,323 times for 71 patients. In total Vonda G Houchin billed 9,024 services in 62 codes, and Medicare paid $135K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,323 | 71 | $0.10 | $419 |
| 99213 Office E&M - Established | Office | 910 | 284 | $51.53 | $47K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 521 | 87 | $0.08 | $39.63 |
| 99307 SNF E&M | Office | 359 | 67 | $26.52 | $9,522 |
| 36415 Venipuncture Blood Collection | Office | 318 | 212 | $8.57 | $2,724 |
| 85025 Blood Count | Office | 252 | 198 | $7.56 | $1,905 |
| 96372 Injection Administration | Office | 251 | 110 | $8.80 | $2,210 |
| 99308 SNF E&M | Office | 231 | 71 | $49.15 | $11K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 136 | 27 | $0.31 | $41.55 |
| 81002 Clinical Chemistry | Office | 132 | 63 | $3.40 | $449 |
| 83036 Blood Count | Office | 120 | 83 | $9.47 | $1,137 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 102 | 102 | $118.43 | $12K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 73 | 34 | $0.88 | $64.04 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 53 | 53 | $151.25 | $8,016 |
| 87804 Immunoassay | Office | 44 | 22 | $16.22 | $714 |
By year: 2022 $134K for 5,146 services; 2023 $117K for 4,821 services; 2024 $135K for 9,024 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 318 | 212 | $8.57 | $2,724 |
| 85025 Blood Count | 252 | 198 | $7.56 | $1,905 |
| 81002 Clinical Chemistry | 132 | 63 | $3.40 | $449 |
| 83036 Blood Count | 120 | 83 | $9.47 | $1,137 |
| 87804 Immunoassay | 44 | 22 | $16.22 | $714 |
| 87635 COVID Specific | 21 | 21 | $50.16 | $1,053 |
Medicare prescription drug claims, 2024
In 2024, the drug Vonda G Houchin prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 984 prescriptions and refills. In total Vonda G Houchin wrote 26,380 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 984 | 984 | 139 | $20K |
| Atorvastatin Calcium Generic | 920 | 1,608 | 177 | $9,948 |
| Levothyroxine Sodium Generic | 813 | 1,379 | 143 | $8,471 |
| Alprazolam Generic | 799 | 809 | 106 | $4,227 |
| Furosemide Generic | 597 | 955 | 131 | $3,332 |
| Pantoprazole Sodium Generic | 587 | 1,050 | 132 | $6,474 |
| Amlodipine Besylate Generic | 537 | 1,002 | 122 | $2,853 |
| Losartan Potassium Generic | 517 | 1,027 | 112 | $4,945 |
| Omeprazole Generic | 484 | 998 | 106 | $5,640 |
| Lisinopril Generic | 483 | 973 | 98 | $3,011 |
| Eliquis Apixaban | 476 | 504 | 53 | $201K |
| Gabapentin Generic | 463 | 709 | 101 | $8,107 |
| Rosuvastatin Calcium Generic | 381 | 755 | 81 | $4,713 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 371 | 443 | 86 | $14K |
| Pravastatin Sodium Generic | 361 | 734 | 74 | $5,068 |
Brand drugs: 3,690 claims; generic drugs: 22,484 claims; opioid claims: 1,703.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vonda G Houchin $7,163 ($1,707 in general payments such as food, travel and fees and $5,456 for research) from 26 companies. The largest payer was Genentech, Inc. with $5,456.
| Company | Payments | Amount |
|---|---|---|
| Genentech, Inc. ROG.SW | 1 | $5,456 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 14 | $239 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 7 | $170 |
| Neurocrine BioSciences, Inc. NBIX | 13 | $167 |
| Abbvie Inc. ABBV | 11 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $133 |
| Axsome Therapeutics, Inc. AXSM | 5 | $108 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $72.17 |
| Pfizer Inc. PFE | 4 | $67.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.